Rheumatoid arthritis

Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

CitH3 is significantly associated with disease activity and could serve as a useful candidate biomarker to assess disease activity in patients with RA.

Study context

Population
Patients with rheumatoid arthritis (RA) and healthy controls151 RA patients · 56 healthy controls
Participants
69 / 32 / 20 / 30 / 56
Exposure
Serum CitH3 levels across RA disease activity categories and healthy controls
  • Highly active RAn = 69
  • Moderately active RAn = 32
  • Mildly active RAn = 20
  • RA in remissionn = 30
  • Healthy controlsn = 56reference
Outcome
Discriminant capacity of serum CitH3 between highly/moderately active RA and RA in remission/mild activity (ROC)
Methodological detailsROC curve analysis, machine-learning predictive model
  • ROC curve analysis
  • Machine-learning predictive model

Main finding

As reported in the abstract

AUC of CitH3 for discriminating RA activity levels

AUC

Highly active RA vs Mildly active RA
0.825
Highly active RA vs RA in remission
0.840
Moderately active RA vs Mildly active RA
0.789
Moderately active RA vs RA in remission
0.829

Observational data: associations, not effects.

Further findings

Correlations of serum CitH3 with disease variables

Positively associated with DAS28-ESR, ESR, CRP, RF, WBC, RDW, PLT, N and N%
Negatively associated with haemoglobin, lymphocyte percentage and thyroid-stimulating hormone

Machine-learning predictive model

Optimal predictive model selected and had high performance

Original publication

Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. Published 15 August 2022. doi:10.55563/clinexprheumatol/i3bcss

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.